| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Animal Model |



From the Department of Neuropathology and Neuroscience,*
Graduate School of Pharmaceutical Sciences, University of Tokyo, Tokyo,
Japan; the Alzheimer Disease Research Unit,
Massachusetts General Hospital, Charlestown, Massachusetts; the Nathan
Kline Institute,
New York University,
Orangeburg, New York; the Laboratory for Proteolytic
Neuroscience,§
Brain Science Institute,
RIKEN, Wako, Japan; the Center for Clinical and Molecular
Neurobiology,¶
Departments of Neurology and
Neuroscience, the University of Minnesota, Minneapolis, Minnesota; and
the Department of Pathological Sciences,||
the University
of Manchester, Manchester, United Kingdom
To analyze the relationship between the deposition of amyloid ß peptides (Aß) and neuronal loss in transgenic models of Alzheimers disease (AD), we examined the frontal neocortex (Fc) and CA1 portion of hippocampus (CA1) in PSAPP mice doubly expressing AD-associated mutant presenilin 1 (PS1) and Swedish-type mutant ß amyloid precursor protein (APPsw) by morphometry of Aß burden and neuronal counts. Deposition of Aß was detected as early as 3 months of age in the Fc and CA1 of PSAPP mice and progressed to cover 28.3% of the superior frontal cortex and 18.4% of CA1 at 12 months: ~20- (Fc) and ~40- (CA1) fold greater deposition than in APPsw mice. There was no significant difference in neuronal counts in either CA1 or the frontal cortex between nontransgenic (non-tg), PS1 transgenic, APPsw, and PSAPP mice at 3 to 12 months of age. In the PSAPP mice, there was disorganization of the neuronal architecture by compact amyloid plaques, and the average number of neurons was 8 to 10% fewer than the other groups (NS, P > 0.10) in CA1 and 2 to 20% fewer in frontal cortex (NS, P = 0.31). There was no loss of total synaptophysin immunoreactivity in the Fc or dentate gyrus molecular layer of the 12-month-old PSAPP mice. Thus, although co-expression of mutant PS1 with Swedish mutant ßAPP leads to marked cortical and limbic Aß deposition in an age-dependent manner, it does not result in the dramatic neuronal loss in hippocampus and association cortex characteristic of AD.
This article has been cited by other articles:
![]() |
G. I. Cancino, E. M. Toledo, N. R. Leal, D. E. Hernandez, L. F. Yevenes, N. C. Inestrosa, and A. R. Alvarez STI571 prevents apoptosis, tau phosphorylation and behavioural impairments induced by Alzheimer's {beta}-amyloid deposits Brain, September 1, 2008; 131(9): 2425 - 2442. [Abstract] [Full Text] [PDF] |
||||
![]() |
D.-S. Yang, A. Kumar, P. Stavrides, J. Peterson, C. M. Peterhoff, M. Pawlik, E. Levy, A. M. Cataldo, and R. A. Nixon Neuronal Apoptosis and Autophagy Cross Talk in Aging PS/APP Mice, a Model of Alzheimer's Disease Am. J. Pathol., September 1, 2008; 173(3): 665 - 681. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Zhu, J. Avila, G. Perry, and M. A. Smith Treating the Lesions, Not the Disease Am. J. Pathol., May 1, 2007; 170(5): 1457 - 1459. [Full Text] [PDF] |
||||
![]() |
P. Du, K. M. Wood, M. H. Rosner, D. Cunningham, B. Tate, and K. F. Geoghegan Dominance of Amyloid Precursor Protein Sequence over Host Cell Secretases in Determining beta-Amyloid Profiles Studies of Interspecies Variation and Drug Action by Internally Standardized Immunoprecipitation/Mass Spectrometry J. Pharmacol. Exp. Ther., March 1, 2007; 320(3): 1144 - 1152. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Drachman Aging of the brain, entropy, and Alzheimer disease Neurology, October 24, 2006; 67(8): 1340 - 1352. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. Robbins, R. A. Betensky, S. B. Domnitz, S. M. Purcell, M. Garcia-Alloza, C. Greenberg, G. W. Rebeck, B. T. Hyman, S. M. Greenberg, M. P. Frosch, et al. Kinetics of Cerebral Amyloid Angiopathy Progression in a Transgenic Mouse Model of Alzheimer Disease J. Neurosci., January 11, 2006; 26(2): 365 - 371. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. E. Klunk, B. J. Lopresti, M. D. Ikonomovic, I. M. Lefterov, R. P. Koldamova, E. E. Abrahamson, M. L. Debnath, D. P. Holt, G.-f. Huang, L. Shao, et al. Binding of the Positron Emission Tomography Tracer Pittsburgh Compound-B Reflects the Amount of Amyloid-{beta} in Alzheimer's Disease Brain But Not in Transgenic Mouse Brain J. Neurosci., November 16, 2005; 25(46): 10598 - 10606. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. R. Jack Jr, T. M. Wengenack, D. A. Reyes, M. Garwood, G. L. Curran, B. J. Borowski, J. Lin, G. M. Preboske, S. S. Holasek, G. Adriany, et al. In Vivo Magnetic Resonance Microimaging of Individual Amyloid Plaques in Alzheimer's Transgenic Mice J. Neurosci., October 26, 2005; 25(43): 10041 - 10048. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. L. Spires, M. Meyer-Luehmann, E. A. Stern, P. J. McLean, J. Skoch, P. T. Nguyen, B. J. Bacskai, and B. T. Hyman Dendritic Spine Abnormalities in Amyloid Precursor Protein Transgenic Mice Demonstrated by Gene Transfer and Intravital Multiphoton Microscopy J. Neurosci., August 3, 2005; 25(31): 7278 - 7287. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. P.F. Rutten, N. M. Van der Kolk, S. Schafer, M. A.M.J. van Zandvoort, T. A. Bayer, H. W.M. Steinbusch, and C. Schmitz Age-Related Loss of Synaptophysin Immunoreactive Presynaptic Boutons within the Hippocampus of APP751SL, PS1M146L, and APP751SL/PS1M146L Transgenic Mice Am. J. Pathol., July 1, 2005; 167(1): 161 - 173. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. D. Stein, N. J. Anders, C. DeCarli, S. L. Chan, M. P. Mattson, and J. A. Johnson Neutralization of Transthyretin Reverses the Neuroprotective Effects of Secreted Amyloid Precursor Protein (APP) in APPSw Mice Resulting in Tau Phosphorylation and Loss of Hippocampal Neurons: Support for the Amyloid Hypothesis J. Neurosci., September 1, 2004; 24(35): 7707 - 7717. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. I. Fonseca, J. Zhou, M. Botto, and A. J. Tenner Absence of C1q Leads to Less Neuropathology in Transgenic Mouse Models of Alzheimer's Disease J. Neurosci., July 21, 2004; 24(29): 6457 - 6465. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kowa, T. Sakakura, Y. Matsuura, T. Wakabayashi, D. M.A. Mann, K. Duff, S. Tsuji, T. Hashimoto, and T. Iwatsubo Mostly Separate Distributions of CLAC- versus A{beta}40- or Thioflavin S-Reactivities in Senile Plaques Reveal Two Distinct Subpopulations of {beta}-Amyloid Deposits Am. J. Pathol., July 1, 2004; 165(1): 273 - 281. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. W. Dickson Building a More Perfect Beast: APP Transgenic Mice with Neuronal Loss Am. J. Pathol., April 1, 2004; 164(4): 1143 - 1146. [Full Text] [PDF] |
||||
![]() |
C. Schmitz, B. P. F. Rutten, A. Pielen, S. Schafer, O. Wirths, G. Tremp, C. Czech, V. Blanchard, G. Multhaup, P. Rezaie, et al. Hippocampal Neuron Loss Exceeds Amyloid Plaque Load in a Transgenic Mouse Model of Alzheimer's Disease Am. J. Pathol., April 1, 2004; 164(4): 1495 - 1502. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Li, D. Cao, D. W. Garber, H. Kim, and K.-i. Fukuchi Association of Aortic Atherosclerosis with Cerebral {beta}-Amyloidosis and Learning Deficits in a Mouse Model of Alzheimer's Disease Am. J. Pathol., December 1, 2003; 163(6): 2155 - 2164. [Abstract] [Full Text] |
||||
![]() |
M. E. McLellan, S. T. Kajdasz, B. T. Hyman, and B. J. Bacskai In Vivo Imaging of Reactive Oxygen Species Specifically Associated with Thioflavine S-Positive Amyloid Plaques by Multiphoton Microscopy J. Neurosci., March 15, 2003; 23(6): 2212 - 2217. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. N. Prasad, W. C. Cole, and K. C. Prasad Risk Factors for Alzheimer's Disease: Role of Multiple Antioxidants, Non-Steroidal Anti-inflammatory and Cholinergic Agents Alone or in Combination in Prevention and Treatment J. Am. Coll. Nutr., December 1, 2002; 21(6): 506 - 522. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Urbanc, L. Cruz, R. Le, J. Sanders, K. H. Ashe, K. Duff, H. E. Stanley, M. C. Irizarry, and B. T. Hyman Neurotoxic effects of thioflavin S-positive amyloid deposits in transgenic mice and Alzheimer's disease PNAS, October 29, 2002; 99(22): 13990 - 13995. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Uryu, H. Laurer, T. McIntosh, D. Pratico, D. Martinez, S. Leight, V. M.-Y. Lee, and J. Q. Trojanowski Repetitive Mild Brain Trauma Accelerates Abeta Deposition, Lipid Peroxidation, and Cognitive Impairment in a Transgenic Mouse Model of Alzheimer Amyloidosis J. Neurosci., January 15, 2002; 22(2): 446 - 454. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Bondolfi, M. Calhoun, F. Ermini, H. G. Kuhn, K.-H. Wiederhold, L. Walker, M. Staufenbiel, and M. Jucker Amyloid-Associated Neuron Loss and Gliogenesis in the Neocortex of Amyloid Precursor Protein Transgenic Mice J. Neurosci., January 15, 2002; 22(2): 515 - 522. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Pratico, K. Uryu, S. Leight, J. Q. Trojanoswki, and V. M.-Y. Lee Increased Lipid Peroxidation Precedes Amyloid Plaque Formation in an Animal Model of Alzheimer Amyloidosis J. Neurosci., June 15, 2001; 21(12): 4183 - 4187. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Matsuoka, M. Picciano, B. Malester, J. LaFrancois, C. Zehr, J. M. Daeschner, J. A. Olschowka, M. I. Fonseca, M. K. O'Banion, A. J. Tenner, et al. Inflammatory Responses to Amyloidosis in a Transgenic Mouse Model of Alzheimer's Disease Am. J. Pathol., April 1, 2001; 158(4): 1345 - 1354. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. S. Turner Alzheimer's Disease in Man and Transgenic Mice : Females at Higher Risk Am. J. Pathol., March 1, 2001; 158(3): 797 - 801. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |